Development of resistance to ceftazidime and co-amoxiclav in Pseudomonas pseudomallei

J Antimicrob Chemother. 1991 Aug;28(2):321-4. doi: 10.1093/jac/28.2.321.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amoxicillin / pharmacology*
  • Amoxicillin / therapeutic use
  • Amoxicillin-Potassium Clavulanate Combination
  • Burkholderia pseudomallei / drug effects*
  • Burkholderia pseudomallei / isolation & purification
  • Ceftazidime / pharmacology*
  • Ceftazidime / therapeutic use
  • Clavulanic Acids / pharmacology*
  • Clavulanic Acids / therapeutic use
  • Drug Resistance, Microbial
  • Drug Therapy, Combination / pharmacology
  • Drug Therapy, Combination / therapeutic use
  • Humans
  • Melioidosis / drug therapy
  • Microbial Sensitivity Tests

Substances

  • Clavulanic Acids
  • Amoxicillin-Potassium Clavulanate Combination
  • Amoxicillin
  • Ceftazidime